Trial Details
COMPLETEDBasic Information
| Clinical ID | c1317 |
|---|---|
| Identifier | NCT03182166 |
| Trial Title | Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Golimumab (Optimization)|DIAGNOSTIC_TEST: Rectosigmoidoscopy|BIOLOGICAL: Blood samples |
Participant Information
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
|---|---|
| City | Amiens |
| Country/Region | France |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2017-11-21 |
|---|---|
| Primary Completion Date | 2021-06-25 |
| Completion Date | 2021-12-15 |